Company Analysis

InflaRx N.V. (IFRX)

Nasdaq: IFRX · Pharmaceutical Preparations · Jena, DE · filing with the SEC since 2017
Grade4.0
◀ Past 4.9● Present 3.5▶ Future 3.8
3 est.

Who owns InflaRx N.V.

As filed with the SEC
Holders of 5% or more
6
Montanova Capital, LLC holds 15.6% of Common Shares, nominal value (euro)0.12 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Montanova Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Shares, nominal value (euro)0.12 per share · 11.7% in Feb 13, 2026
15.6%
TCG Crossover GP III, LLC
SCHEDULE 13G · filed May 12, 2026 · Ordinary Shares, nominal value (euro)0.12 per share
9.8%
Sirenia Capital Management LP
SCHEDULE 13G · filed Aug 14, 2026 · Ordinary Shares, nominal value 0.12 euro per share
6.1%
Fmr LLC
5.5%
Commodore Capital LP
SCHEDULE 13G · filed Aug 17, 2026 · Ordinary Shares, nominal value 0.12 EUR per share
5.1%
Dapice Joshua J.
SCHEDULE 13G · filed May 14, 2026 · Ordinary Shares, nominal value 0.12 EUR per share (the "Shares")
5.1%
Farallon Capital Management, L.L.C.
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, nominal value 0.12 EUR per share (the "Shares") · reported falling below 5%
under 5%
What IFRX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Compensation Expense for Non Executive Directors
A company bought · acquisition · owns, named in the 20-F filed Mar 20, 2026
Legal and Consulting
A company bought · acquisition · owns, named in the 20-F filed Mar 20, 2026
Legal and Consulting Fees
A company bought · acquisition · owns, named in the 20-F filed Mar 20, 2026

2 subsidiaries in 2 countries, from the list filed with the 20-F filed Mar 20, 2026.

Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton IFRX · research, not advice